BMC Cancer (Oct 2006)

High-resolution analysis of HLA class I alterations in colorectal cancer

  • Jan Fleuren Gert,
  • van de Velde Cornelis JH,
  • Claas Frans HJ,
  • Verduyn Willem,
  • van Puijenbroek Marjo,
  • Mulder Arend,
  • de Miranda Noel FCC,
  • Dierssen Jan Willem F,
  • Cornelisse Cees J,
  • Corver Willem E,
  • Morreau Hans

DOI
https://doi.org/10.1186/1471-2407-6-233
Journal volume & issue
Vol. 6, no. 1
p. 233

Abstract

Read online

Abstract Background Previous studies indicate that alterations in Human Leukocyte Antigen (HLA) class I expression are frequent in colorectal tumors. This would suggest serious limitations for immunotherapy-based strategies involving T-cell recognition. Distinct patterns of HLA surface expression might conceal different immune escape mechanisms employed by the tumors and are worth further study. Method We applied four-color multiparameter flow cytometry (FCM), using a large panel of alloantigen-specific anti-HLA-A and -B monoclonal antibodies, to study membranous expression of individual HLA alleles in freshly isolated colorectal cancer cell suspensions from 21 patients. Results Alterations in HLA class I phenotype were observed in 8 (38%) of the 21 tumors and comprised loss of a single A or B alleles in 4 cases, and loss of all four A and B alleles in the other 4 cases. Seven of these 8 tumors were located on the right side of the colon, and those showing loss of both HLA-A and -B membranous expression were all of the MSI-H phenotype. Conclusion FCM allows the discrimination of complex phenotypes related to the expression of HLA class I. The different patterns of HLA class I expression might underlie different tumor behavior and influence the success rate of immunotherapy.